Modernizing antibiotic regimens for obstetric infections through antimicrobial stewardship

Karley Dutra1, Bryan Hess2

  • 1Department of Obstetrics and Gynecology (Dutra), Thomas Jefferson University Hospital, Philadelphia, PA.

Maternal sepsis remains a major and largely preventable contributor to maternal morbidity and mortality, with intra-amniotic infection and postpartum endometritis remaining common obstetric sources of sepsis. Intra-amniotic infection complicates approximately 2%-5% of term deliveries, and postpartum endometritis occurs in up to 7% of births. Both conditions are typically polymicrobial, arising from ascending infection involving gram-positive, gram-negative, and anaerobic organisms. Despite rising antimicrobial resistance, the recommended antibiotic regimens for obstetric infections have remained unchanged since the 1980's. Current guidelines endorse ampicillin and gentamicin, with the addition of clindamycin at the time of cesarean delivery, for the treatment of intra-amniotic infection based on heterogeneous and largely dated studies. Gentamicin and clindamycin remain the mainstay of treatment for postpartum endometritis. Evidence guiding optimal dosing strategies, antibiotic selection, and postpartum duration of therapy remains limited for both clinical entities. Concerns regarding the continued effectiveness of these regimens include increasing antimicrobial resistance among Enterobacterales, anaerobes, and group B streptococcus, and recent aminoglycoside breakpoint changes necessitating higher gentamicin dosing. Antimicrobial stewardship offers an opportunity to modernize obstetric infection management through institution-specific antibiograms and multidisciplinary collaboration among obstetric, infectious diseases, pharmacy, and microbiology teams. Leveraging local resistance data to tailor antibiotic selection aligns with contemporary sepsis management principles and may improve safety, efficiency, and antimicrobial sustainability. In the absence of new randomized controlled trials, stewardship-driven, evidence-informed approaches represent a practical strategy to optimize treatment of intra-amniotic infection and postpartum endometritis in modern obstetric practice.

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antibiotic Selection00:57

Antibiotic Selection

Overview